Advertisement
UK markets closed

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,207.13
    +444.10 (+2.50%)
     

  • CRUDE OIL

    79.16
    +0.21 (+0.27%)
     

  • GOLD FUTURES

    2,314.60
    +5.00 (+0.22%)
     

  • DOW

    38,225.66
    +322.37 (+0.85%)
     

  • Bitcoin GBP

    47,276.42
    +1,120.18 (+2.43%)
     

  • CMC Crypto 200

    1,278.81
    +8.07 (+0.63%)
     

  • NASDAQ Composite

    15,840.96
    +235.48 (+1.51%)
     

  • UK FTSE All Share

    4,446.15
    +27.55 (+0.62%)
     
Money:

Best UK mortgage deals of the week

The cheapest home loans available now

Astra looking to partner or sell infection, neuroscience drugs

Reuters - UK Focus

LONDON, April 24 (Reuters) - AstraZeneca (NYSE: AZN - news) is looking to partner or sell its anti-infective and neuroscience drugs, since these products are no longer core areas for the British drugmaker, its chief executive said on Thursday.

Pascal Soriot told reporters in a first-quarter conference call that he was investigating all options for the businesses as the drugmaker redeploys resources to the priority areas of oncology, cardiovascular and metabolic diseases, and respiratory and inflammation.

(Reporting by Ben Hirschler; Editing by Mark Potter)